EOT.L

European Opportunities Trust Plc
European Opps. Trust - Portfolio Update
4th December 2024, 13:49
TwitterFacebookLinkedIn
To continue viewing RNS, please confirm that you are a Private Investor*

* A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

  1. Obtains access to the information in a personal capacity;
  2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
  3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
  4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
  5. Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
  6. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
RNS Number : 8363O
European Opportunities Trust PLC
04 December 2024
 

EUROPEAN OPPORTUNITIES TRUST PLC

             

Legal Entity Identifier: 549300XN7RXQWHN18849

             

Month end portfolio information as at 30 November 2024

 

Total Net Assets: £ 579,780,740

 

Total Assets (including drawdown bank debt):  £ 649,780,740

 

Top Twenty Holdings

            

Stock

Sector

Country of Listing

% of Total Assets (Incl Drawn down bank debt)

Novo Nordisk A/S-B

Health Care

Denmark

11.3

Experian Plc

Industrials

United Kingdom

8.1

Relx Plc

Industrials

Netherlands

7.7

Deutsche Boerse AG

Financials

Germany

7.4

Dassault Systemes SE

Information Technology

France

6.9

Intermediate Capital Group

Financials

United Kingdom

5.5

Genus Plc

Health Care

United Kingdom

5.0

Edenred

Financials

France

4.6

Prysmian SPA

Industrials

Italy

4.5

Infineon Technologies AG

Information Technology

Germany

4.1

Gaztransport Et Technigaz SA

Energy

France

3.9

Biomerieux

Health Care

France

3.8

Camurus AB

Health Care

Sweden

3.6

Grifols SA

Health Care

Spain

3.5

Ryanair Holdings ADR

Industrials

Ireland

3.1

Oxford Instruments Plc

Information Technology

United Kingdom

2.5

Genmab A/S

Health Care

Denmark

1.6

BAE Systems

Industrials

United Kingdom

1.5

CTS Eventim AG

Communication Services

Germany

1.5

Universal Music Group

Communication Services

Netherlands

1.4

 

Country of listing of investee companies

 

 Country

% of Total assets (including drawn down bank debt)

France

23.2

United Kingdom

  23.1

Germany

 13.1

Denmark

12.9

Netherlands

9.8

Italy

5.6

Sweden

4.3

Spain

3.5

Ireland

3.1

Switzerland

0.9

Cash/(Gearing)

0.5

 

Market Capitalisation of investee companies

 

 Market Cap

% of Total Assets (including Drawn down bank debt)

Large

85.1

Mid

14.1

Small

0.3

Cash/(Gearing)

0.5

             

 

The Company's most recent report and accounts and further information for shareholders is published on the Company's website at www.europeanopportunitiestrust.com

 

Enquiries:

 

Devon Equity Management Limited,

Company Secretaries to European Opportunities Trust PLC

Richard Pavry

020 3985 0441

enquiries@devonem.com   

              

04 December 2024

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PFUBXBDDISGDGSS]]>
TwitterFacebookLinkedIn